Paloma Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,439
| Closed | -$233K | – | 686 |
|
|
2024
Q3 | $233K | Sell |
1,439
-18,294
| -93% | -$2.91M | 0.01% | 916 |
|
|
2024
Q2 | $2.88M | Buy |
19,733
+11,673
| +145% | +$1.74M | 0.08% | 264 |
|
|
2024
Q1 | $1.28M | Buy |
8,060
+2,714
| +51% | +$432K | 0.07% | 290 |
|
|
2023
Q4 | $838K | Buy |
+5,346
| New | +$820K | 0.03% | 449 |
|
|
2022
Q2 | – | Sell |
-20,196
| Closed | -$3.6M | – | 1413 |
|
|
2022
Q1 | $3.58M | Buy |
20,196
+16,433
| +437% | +$2.8M | 0.11% | 125 |
|
|
2021
Q4 | $644K | Buy |
+3,763
| New | +$616K | 0.01% | 971 |
|
|
2021
Q3 | – | Sell |
-106,100
| Closed | -$17.5M | – | 1498 |
|
|
2021
Q2 | $17.5M | Buy |
+106,100
| New | +$17.6M | 0.32% | 55 |
|
|
2021
Q1 | – | Sell |
-20,833
| Closed | -$3.28M | – | 2198 |
|
|
2020
Q4 | $3.28M | Sell |
20,833
-56,154
| -73% | -$8.29M | 0.09% | 252 |
|
|
2020
Q3 | $11.5M | Sell |
76,987
-154,183
| -67% | -$22.8M | 0.29% | 45 |
|
|
2020
Q2 | $32.5M | Buy |
+231,170
| New | +$33.7M | 0.56% | 18 |
|
|
2020
Q1 | – | Sell |
-19,775
| Closed | -$2.88M | – | 1658 |
|
|
2019
Q4 | $2.88M | Sell |
19,775
-54,605
| -73% | -$7.41M | 0.04% | 443 |
|
|
2019
Q3 | $9.62M | Buy |
74,380
+14,735
| +25% | +$1.94M | 0.2% | 72 |
|
|
2019
Q2 | $8.31M | Buy |
59,645
+45,359
| +318% | +$6.28M | 0.14% | 126 |
|
|
2019
Q1 | $2M | Buy |
14,286
+8,901
| +165% | +$1.19M | 0.05% | 447 |
|
|
2018
Q4 | $695K | Sell |
5,385
-17,038
| -76% | -$2.38M | 0.02% | 564 |
|
|
2018
Q3 | $3.1M | Sell |
22,423
-108,650
| -83% | -$14.4M | 0.06% | 302 |
|
|
2018
Q2 | $15.9M | Buy |
131,073
+122,566
| +1,441% | +$15.3M | 0.29% | 45 |
|
|
2018
Q1 | $1.09M | Sell |
8,507
-30,372
| -78% | -$4.11M | 0.02% | 949 |
|
|
2017
Q4 | $5.43M | Sell |
38,879
-7,291
| -16% | -$1.02M | 0.07% | 255 |
|
|
2017
Q3 | $6M | Sell |
46,170
-90,437
| -66% | -$12M | 0.08% | 238 |
|
|
2017
Q2 | $18.1M | Buy |
136,607
+49,339
| +57% | +$6.29M | 0.21% | 52 |
|
|
2017
Q1 | $10.9M | Buy |
87,268
+32,802
| +60% | +$3.92M | 0.13% | 112 |
|
|
2016
Q4 | $6.28M | Buy |
54,466
+26,728
| +96% | +$3.09M | 0.06% | 204 |
|
|
2016
Q3 | $3.28M | Buy |
27,738
+13,766
| +99% | +$1.67M | 0.04% | 333 |
|
|
2016
Q2 | $1.7M | Sell |
13,972
-7,228
| -34% | -$821K | 0.02% | 829 |
|
|
2016
Q1 | $2.29M | Buy |
21,200
+11,087
| +110% | +$1.15M | 0.04% | 424 |
|
|
2015
Q4 | $1.04M | Sell |
10,113
-17,676
| -64% | -$1.78M | 0.03% | 660 |
|
|
2015
Q3 | $2.59M | Sell |
27,789
-61,612
| -69% | -$5.96M | 0.06% | 258 |
|
|
2015
Q2 | $8.71M | Buy |
89,401
+71,626
| +403% | +$7.17M | 0.17% | 125 |
|
|
2015
Q1 | $1.79M | Sell |
17,775
-134,058
| -88% | -$13.6M | 0.05% | 325 |
|
|
2014
Q4 | $15.9M | Buy |
+151,833
| New | +$16M | 0.68% | 24 |
|
|
2014
Q3 | – | Sell |
-4,700
| Closed | -$487K | – | 1173 |
|
|
2014
Q2 | $491K | Sell |
4,700
-132
| -3% | -$13.3K | 0.02% | 592 |
|
|
2014
Q1 | $475K | Sell |
4,832
-10,399
| -68% | -$964K | 0.03% | 401 |
|
|
2013
Q4 | $1.4M | Buy |
15,231
+11,931
| +362% | +$1.1M | 0.07% | 277 |
|
|
2013
Q3 | $286K | Sell |
3,300
-4,915
| -60% | -$441K | 0.01% | 662 |
|
|
2013
Q2 | $705K | Buy |
+8,215
| New | +$697K | 0.04% | 362 |
|
Other funds holding JNJ
Paloma Partners's JNJ Position: Q4 2024 in Review
Paloma Partners sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 1,439 shares — an estimated $233K sold.
Paloma Partners first reported a position in JNJ in Q2 2013 and held it in 36 quarters. The position peaked at $32.5M in Q2 2020. 4,104 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.
- Paloma Partners reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
- Paloma Partners sold 1,439 Johnson & Johnson shares in Q4 2024, an estimated $233K.
- Paloma Partners first reported a position in Johnson & Johnson in Q2 2013 and held it in 36 quarters.
- Paloma Partners's Johnson & Johnson position peaked at $32.5M in Q2 2020.
- 4,104 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.
Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.